Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 3/20 | 0.60 |
| ▸ | PLK1 | P53350 | 3/20 | 0.56 |
| ▸ | RARB | P10826 | 4/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | DRD4 | P21917 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | HRH2 | P25021 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
| ▸ | SCN1A | P35498 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10534588 | 0.98 | HCAR3 (0.59) | HCAR3PLK1RARBTP53TSHR | |
| SCHEMBL10950807 | 0.98 | HCAR3 (0.59) | HCAR3PLK1RARBTP53TSHR | |
| SCHEMBL6372020 | 0.98 | HCAR3 (0.59) | HCAR3PLK1RARBTP53TSHR | |
| SCHEMBL11280086 | 0.98 | HCAR3 (0.59) | HCAR3PLK1RARBTP53TSHR | |
| SCHEMBL11278167 | 0.98 | HCAR3 (0.59) | HCAR3PLK1RARBTP53TSHR | |
| SCHEMBL11283832 | 0.98 | HCAR3 (0.59) | HCAR3PLK1RARBTP53TSHR | |
| Cetaben SCHEMBL2112078 | 0.98 | HCAR3 (0.59) | HCAR3PLK1RARBTP53TSHR | |
| SCHEMBL2309354 | 0.98 | HCAR3 (0.59) | HCAR3PLK1RARBTP53TSHR | |
| SCHEMBL22398313 | 0.98 | HCAR3 (0.59) | HCAR3PLK1RARBTP53TSHR | |
| SCHEMBL11478101 | 0.98 | HCAR3 (0.59) | HCAR3PLK1RARBTP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5248753-A | Aromatic copolymers | ENIRICERCHE S.P.A. (IT) | 1993-09-28 | — | — | US | claimed |
| EP-0429127-B1 | THERMOTROPIC COPOLYESTERAMIDE, PROCESS FOR ITS PREPARATION AND UTILIZATION | ENIRICERCHE S.p.A. (IT) | 1993-09-15 | — | — | EP | claimed |
| EP-0430326-B1 | THERMOTROPIC COPOLYESTERAMIDE, PROCESS FOR ITS PREPARATION AND UTILIZATION | ENIRICERCHE S.p.A. (IT) | 1993-06-16 | — | — | EP | claimed |
| EP-0430326-A1 | Thermotropic copolyesteramide, process for its preparation and utilization | ENIRICERCHE S.p.A. (IT) | 1991-06-05 | — | — | EP | claimed |
| EP-0429127-A1 | Thermotropic copolyesteramide, process for its preparation and utilization | ENIRICERCHE S.p.A. (IT) | 1991-05-29 | — | — | EP | claimed |
| US-4182842-A | MOLDING MATERIALS | EASTMAN KODAK COMPANY (US) | 1980-01-08 | — | — | US | claimed |
| WO-2025086591-A1 | ROTIGOTINE PRODRUG DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 烟台药物研究所 | 2025-05-01 | — | — | WO | disclosed |
| US-20230139366-A1 | BRARTEMICIN ANALOGUES | VICTORIA LINK LIMITED (NZ) | 2023-05-04 | — | — | US | disclosed |
| CN-111307773-B | Application of fluorescent compound in detecting and/or distinguishing natural plant compounds | 北京理工大学 | 2021-05-11 | — | — | CN | disclosed |
| CN-111307773-A | Application of fluorescent compound in detecting and/or distinguishing natural plant compounds | 北京理工大学 | 2020-06-19 | — | — | CN | disclosed |
| US-20170135933-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING PHOTOSENSITIVE 1,3,5-TRIAZINE COMPOUNDS, DIBENZOYLMETHANE COMPOUNDS AND SILICEOUS S-TRIAZINES SUBSTITUTED WITH TWO AMINOBENZOATE OR AMINOBENZAMIDE GROUPS | L'OREAL (FR) | 2017-05-18 | — | — | US | disclosed |
| US-9526924-B2 | Composition comprising a screening agent of the lipophilic 2-hydroxybenzophenone type and a silicon-compromising s-triazine substituted by at least two alkylaminobenzoate groups | L'OREAL (FR) | 2016-12-27 | — | — | US | disclosed |
| US-8999299-B2 | Photoprotective cosmetic compositions comprising silicon-containing s-triazine compounds substituted with two aminobenzoate or aminobenzamide groups and non-silicon-containing lipophilic triazine compound UV-screening agents | L'OREAL (FR) | 2015-04-07 | — | — | US | disclosed |
| US-4339375-A | Poly(ester-amide) capable of forming an anisotropic melt phase derived from p-hydroxybenzoic acid, 2,6-dihydroxynaphthalene, carbocyclic dicarboxylic acid, aromatic monomer capable of forming an amide linkage, and, optionally, additional aromatic diol | CELANESE CORPORATION (US) | 1982-07-13 | — | — | US | disclosed |
| EP-0053940-A1 | Poly(ester-amide) capable of forming an anisotropic melt phase derived from 6-hydroxy-2-naphthoic acid, dicarboxylic acid and aromatic monomer capable of forming an amide linkage | CELANESE CORPORATION (US) | 1982-06-16 | — | — | EP | disclosed |
| US-4330457-A | Poly(ester-amide) capable of forming an anisotropic melt phase derived from 6-hydroxy-2-naphthoic acid, dicarboxylic acid, and aromatic monomer capable of forming an amide linkage | CELANESE CORPORATION (US) | 1982-05-18 | — | — | US | disclosed |
| US-4182842-A | MOLDING MATERIALS | EASTMAN KODAK COMPANY (US) | 1980-01-08 | — | — | US | disclosed |
| US-4182842-A | MOLDING MATERIALS | EASTMAN KODAK COMPANY (US) | 1980-01-08 | — | — | US | disclosed |
| US-4182842-A | MOLDING MATERIALS | EASTMAN KODAK COMPANY (US) | 1980-01-08 | — | — | US | disclosed |
| US-3966902-A | HYDROXYALKYL UNSATURATED CARBOXYLATE, BOUND AL, ZN, OR ZR | AIRWICK INDUSTRIES, INC. (US) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139366-A1 | BRARTEMICIN ANALOGUES | RXFP1, RXFP2, RXFP4 | HCAR3 276/4885PLK1 2851/4885RARB 1121/4885 |
| US-20170135933-A1 | PHOTOPROTECTIVE COMPOSITIONS COMPRISING PHOTOSENSITIVE 1,3,5-TRIAZINE COMPOUNDS, DIBENZOYLMETHANE COMPOUNDS AND SILICEOUS S-TRIAZINES SUBSTITUTED WITH TWO AMINOBENZOATE OR AMINOBENZAMIDE GROUPS | CUTA, TST, DSG1 | HCAR3 3212/4885PLK1 1074/4885RARB 745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.